Nomantu Nkomo-Ralehoko’s comeback as Gauteng health MEC sparks mixed reactions

ANC support in Gauteng dipped below 40% in the recent provincial elections and an ANC-lead minority government is now at the helm. Among those in Premier Panyaza Lesufi’s new Cabinet is Nomantu Nkomo-Ralehoko who’s been reappointed as MEC for health and wellness. Spotlight’s Ufrieda Ho rounds up some responses to her return.

Read More

EDITORIAL | Motsoaledi’s return could work, but he needs a DG who can say “no minister”

In some respects, Dr Aaron Motsoaledi was the right person for the job when he was appointed as South Africa’s Minister of Health in 2009. But in 2024, the healthcare context in the country looks very different. Spotlight editor Marcus Low asks what we might expect from this new chapter with Motsoaledi in the top health job.

Read More

Cutting edge robotic surgery: Beacons of excellence at two Cape Town public hospitals

Within South Africa’s beleaguered public health sector – unsettled by budget cuts, understaffing, and divisive NHI legislation – cutting edge surgical robots that have been used to perform more than 600 surgeries at two Cape Town public hospitals are beacons of excellence that offer a glimmer of hope. Spotlight’s Biénne Huisman visited Dr Tim Forgan at Tygerberg Hospital to learn more.

Read More

HPV vaccination switching to single-dose and private schools to get government supply

A decade into South Africa’s HPV vaccination programme, the health department is switching from a two-dose to a single dose vaccine regimen and girls in private schools are set to start receiving government subsidised jabs. The vaccine provided, GlaxoSmithKline’s Cervarix, will remain the same. The move is backed by evidence showing one-dose regimens provide similar protection against HPV infection as multi-dose regimens. Catherine Tomlinson reports.

Read More

Why a major finding on HIV and statins may not be that relevant in SA

One of the biggest stories in HIV in the last year was that a class of medicines called statins could help reduce cardiovascular disease in people living with the virus. In response, treatment guidelines in the United States were quickly updated, but the picture is more complicated in South Africa. Spotlight’s Elri Voigt explores why the case for widespread use of statins by people living with HIV is less compelling in South Africa than in some other countries.

Read More

In the Spotlight | HIV prevention injections exist, but hardly anyone can get them

HIV prevention injections have been registered for use in South Africa, but their high price and limited supply means that for the next few years, while awaiting more affordable generics, very few people will be able to get the jabs. In this Spotlight special briefing, Catherine Tomlinson looks at the difficult choices facing the country if we want to offer the injection to more people more quickly. The calls we make could have global implications.

Read More